News
4h
Zacks Investment Research on MSNAstraZeneca Stock Declines 6% in 3 Months: Time to Buy the Dip?AstraZeneca AZN stock has declined 6.4% in the past three months. Although AstraZeneca faces its share of challenges, a ...
The U.S. Department of Health and Human Services said on Tuesday it would set drug prices pegged to the lowest level paid by ...
Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein(a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...
Company has Pundarikashyam & Associates as its auditors. As on 31-03-2025, the company has a total of 1.00 Crore shares outstanding.Concord Drugs Share Price Today is Rs. 32.30. On previous day, the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results